• Biocartis announces US FDA 510(k) submission of its Idylla™ MSI Test

    Tuesday April 20th 2021

  • PCR speekseltesten op de werkvloer identificeren besmette laag-risico contacten zonder symptomen en helpen de verdere verspreiding tegengaan

    Monday April 19th 2021

  • Latest Neuropixels probes can track neurons over weeks

    Friday April 16th 2021

  • Mayne Pharma and Mithra announce FDA approval of new oral contraceptive Estelle®

    Friday April 16th 2021

  • Antelope DX to join forces with In The Pocket and Extra Horizon for the development of its easy-to-use, high-quality home testing device

    Friday April 16th 2021

  • The European Circular Bioeconomy Fund (ECBF) expands Aphea.Bio Series B funding round to EUR 18 million

    Wednesday April 14th 2021

  • VIB and ILVO launch new start-up Protealis to support sustainable plant protein production

    Thursday April 8th 2021

  • 'We went here, there and everywhere to make it happen'

    Thursday April 8th 2021

  • Your news here?

  • Oxurion NV – Publication in Progress in Retinal Eye Research highlights the potential of pan-RGD integrin antagonists to improve the treatment of diabetic retinopathy and wet AMD

    Thursday April 8th 2021

  • Montis Biosciences appoints René Hoet as Chief Scientific Officer

    Thursday April 1st 2021

  • Confo Therapeutics awarded EUR 1M VLAIO grant for pre-clinical development of CFTX-1554

    Wednesday March 31st 2021


Strategic Partners